3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow AEGR-733: new trials by email Literature Review of AEGR-733 trials Research Report on AEGR-733
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate Safety and Efficacy of AEGR-733 and Atorvastatin vs Atorvastatin Monotherapy in Hypercholesterolemia Atorvastatin, AEGR-733 - Hypercholesterolemia | Phase 2 | Completed | Aegerion Pharmaceuticals, Inc. | 44 | 2008-05-01 | 2018-02-23 |
| Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS AEGR-733, placebo, AEGR-733 and atorvastatin - Hyperlipidemia | Phase 2 | Completed | Aegerion Pharmaceuticals, Inc. | 260 | 2007-10-01 | 2018-02-23 |
| Safety, Tolerability and Efficacy of Microsomal Triglyceride Protein (MTP) Inhibitor Lomitapide - Homozygous Familial Hypercholesterolemia | Phase 2 | Completed | Aegerion Pharmaceuticals, Inc. | 6 | 2003-06-01 | 2013-04-10 |
Hyperlipidemias (2) · Homozygous Familial Hypercholesterolemia (1) · Hypercholesterolemia (1)
Aegerion Pharmaceuticals, Inc. (3)
United States (3)
Dan J Rader, MD (1) · Steven Belknap, MD (1) · William Sasiela, PhD (1)